Last reviewed · How we verify

NCT01585675

Specimen Banking From Patients With Lung Cancer

Recruiting now Last updated 29 January 2026
What this trial tests

trial in Lung Neoplasms in 2,000 participants. Currently enrolling.

Timeline
3 November 2005
Primary endpoint
1 July 2035
1 July 2035

Quick facts

Lead sponsorUniversity of Colorado, Denver
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment2,000
Start date3 November 2005
Primary completion1 July 2035
Estimated completion1 July 2035
Sites1 location across United States

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

Adults 18 to 85, any sex, with Lung Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lung Neoplasms

Currently open trials in the same condition.

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01585675.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing